X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://finance.yahoo.com/news/why-liver-disease-drug-developer-201415125.html
https://www.globenewswire.com/news-release/2024/04/19/2866379/0/en/Hepion-Pharmaceuticals-Initiates-Wind-Down-Activities-in-Phase-2b-ASCEND-NASH-Trial.html
https://www.globenewswire.com//news-release/2024/03/06/2841417/0/en/Hepion-Pharmaceuticals-Strengthens-Board-of-Directors-with-Appointment-of-Michael-Purcell.html
https://www.globenewswire.com//news-release/2024/02/16/2830728/0/en/Hepion-Pharmaceuticals-Announces-Exercise-of-Warrants-for-Approximately-2-0-Million-Aggregate-Gross-Proceeds.html
https://www.globenewswire.com//news-release/2024/01/03/2803663/0/en/Hepion-Pharmaceuticals-to-Present-at-NASH-TAG-2024.html
https://www.fiercebiotech.com/biotech/hepions-nash-trial-hangs-balance-biotech-cuts-costs-60-ceo-departs
https://endpts.com/nash-drugmaker-hepion-to-seek-strategic-alternatives/
https://www.globenewswire.com//news-release/2023/12/07/2792459/0/en/Hepion-Pharmaceuticals-Announces-Restructuring-Plan-to-Enhance-Shareholder-Value-and-Management-Changes.html
https://www.globenewswire.com//news-release/2023/11/28/2787371/0/en/Hepion-Pharmaceuticals-to-Present-at-the-7th-Obesity-NASH-Drug-Development-Summit.html
https://www.globenewswire.com//news-release/2023/11/13/2779461/0/en/Hepion-Pharmaceuticals-Announces-Major-Reductions-in-Liver-Stiffness-with-Rencofilstat-Treatment-in-17-week-Phase-2-Study-of-Advanced-F3-MASH-Liver-Disease.html
Market Place
Share 
